Best Biotech Product Launch Podcasts (2025)

1
Build the Company You Say You Are: How culture shapes real-world execution 31:37

Play Pause

8d ago31:37

31:37

In this episode, Kim speaks with Jill Milne, Ph.D., CEO of Astria Therapeutics, about what it really takes to build a biotech company around patient needs, not just in mission statements, but in everyday decisions. Drawing on her 25+ years in pharma and biotech, Jill shares how Astria is redefining what it means to be patient-first, why culture is …

1
Launching Healthtech Wearables in Hospitals | Shreya Divatia 34:45

19d ago34:45

34:45

In this episode of LifeSci Continuum, I sit down with Shreya Divatia. Shreya has spent a decade rescuing med-tech programs from hidden failure points and turning “it works in the lab” into “it works on a 102-year-old patient with spotty Wi-Fi.” Learn how I can help you buid a bridge between your business strategy and real growth as a Fractional Chi…

1
From Vision to Viability: The Decisions That Define a Biotech 23:26

20d ago23:26

23:26

What does it really take to launch a biotech company that lasts? In this episode, host Kim Kushner sits down with Dr. Marcia de Souza Lima, a physician-executive whose journey spans clinical care, global pharma, investment, and startup leadership. Together, they explore the earliest days of company formation—where every decision, from team design t…

1
Use an FCMO to Transform Marketing Waste into Full Throttle Growth 34:45

27d ago34:45

34:45

In this episode of LifeSci Continuum, I sit down with Pete Tortorell, GM/Managing Director of Omni International (now Revvity). Timestamps: 00:00 Intro 01:24 Pete’s Story 02:07 COVID19 Case Study 07:20 Good Marketing is Hard to Find 12:00 Working with MESH Interactive 13:32 Lead Generation 14:50 Measuring KPIs 17:20 The Value of a FCMO 24:30 Market…

1
Turn Your Bench-Top Idea into a Reimbursable Diagnostic | Laurel Nelson 43:46

1M ago43:46

43:46

In this episode of LifeSci Continuum, I sit down with Laurel Nelson (Founder, InnovexDx), who breaks down how diagnostics and life-science start-ups can actually commercialize when cash is tight and timelines keep slipping. Learn how I can help you grow your business as a Fractional Chief Marketing Officer. https://meshagency.com/fcmo-fractional-cm…

1
Five Fundamentals for Building a Biotech That Lasts 36:23

1M ago36:23

36:23

In this episode of The Emerging Biotech Leader, host Kim Kushner speaks with Al Beardsley, CEO of Cirius Therapeutics, about the foundational principles that guide sustainable biotech company building. A seasoned operator with experience across early discovery and late-stage development, Al introduces his “Five P’s” framework—a practical, clear-eye…

1
The Many Shapes of a CMO 15:36

2M ago15:36

15:36

In this episode, Chief Business Officer Kim Kushner talks with Dr. Carrie Brownstein, SVP Medical at SSI Strategy, about how to think through the fit between a biotech leader and their company’s stage of development. Carrie shares lessons from her own path from large pharma to biotech and how different kinds of experience shape what a CMO can offer…

1
Expanding the CMO Role: The Value of Difference 35:01

2M ago35:01

35:01

In this episode of The Emerging Biotech Leader, Chief Business Officer Kim Kushner and Dr. Carrie Brownstein, SVP Medical at SSI Strategy are joined by Dr. Chrystal Louis, Chief Medical Officer at TScan Therapeutics, to discuss how different professional experiences shape leadership approaches in the biotechnology sector. Dr. Louis brings extensive…

1
Get Better Leads at Your Conference | Bill Kenney 49:03

2M ago49:03

49:03

In this episode of LifeSci Continuum, I sit down with Bill Kenney, Founder of MEET (My Expo & Event Team), to unpack why most life science and med device trade show strategies fail—and how to fix them. Timestamps: 00:00 Intro 01:28 Bill Kenney’s Work in Bio-Tech 02:30 In-Person Inbound Marketing 03:20 How We Met 03:35 How to Get High Quality Leads …

1
Tailor Your Pitch for VC | David Iannetta 18:29

3M ago18:29

18:29

Connect with Dave Iannetta on Linkedin: https://www.linkedin.com/in/dave-iannetta/ Interested in getting 18+ Years of Cheat Codes, Perspective, and Tips for Surviving Marketing in Life Sciences and Medical Devices? • Subscribe to Bill Schick’s Newsletter on LinkedIn https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=715451839032428…

1
How to Bring Pharma to Market by Mastering Brand, Story, and Value | Nara Daubeney 31:14

4M ago31:14

31:14

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Contact Nara Daubeney: https://www.linkedin.com/in/nara-daubeney/ _______________________________ Timestamps: 00:00 Intro 01:31 About Nara…

1
How to Maximize Your Pitch for Angel, VC, and IPO Investors | David Iannetta 11:53

4M ago11:53

11:53

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Dave: https://www.linkedin.com/in/dave-iannetta/ _______________________________ Timestamps: 00:00 Intro 01:37 Telling a Story that…

1
Enabling Successful Sites, Episode 5: Strategies for improving communication between sites, sponsors and CROs 22:38

5M ago22:38

22:38

Investigative sites have shared that one of their top frustrations with the clinical trial process is with the poor communication flow and overall lack of responsiveness from sponsors and CROs. In this episode of ‘Enabling Successful Sites’, Karen McIntyre, Vice President, Global Site Alliances sits down with Jakub Jedrzejewski, Global Project Mana…

1
Is there room for new COAs in neuroscience? 28:32

5M ago28:32

28:32

As we strive to improve health outcomes for patients with neurological conditions, the development of new clinical outcomes assessments (COAs) is crucial. Advancements in COAs are at a tipping point, significantly impacting the future of clinical trials and patient care. Our clinical development and regulatory experts discuss the importance of deve…

1
Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention 8:17

6M ago8:17

8:17

AI is becoming increasingly prevalent in the healthcare industry and clinical research. For clinical trial recruitment, AI can be extremely helpful in finding potential patient volunteers as well improving overall retention rates. In part two of this ‘Enabling Successful Sites’ podcast episode on improving patient recruitment and retention, Karen M…

1
Enabling Successful Sites: Episode 4, Part One: Partnering with sites to improve patient recruitment and retention 26:56

6M ago26:56

26:56

Patient recruitment continues to be a major cost driver and top challenge in clinical research. More than half of sites have to pay recruitment expenses out of their own funds, as sponsor budgets won’t cover some of necessary education and recruitment practices that sites must perform in order to meet enrollment goals and stay in business. This ‘En…

1
What Are The 5 Stages of Buyer Awareness in the Life Sciences? 27:46

7M ago27:46

27:46

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 How to Tailor Your Messaging to Each Awareness Stage and Accelerate Your Life Science Sales: “Marketing doesn’t work for us.” Yeah, I hear…

1
The Road Ahead: Biotech in 2025 36:35

7M ago36:35

36:35

As biotech innovation accelerates across therapeutic areas organizations face complex strategic decisions about their future. In this episode of The Emerging Biotech Leader, former EMA Director Dr. Thomas Lönngren offers insights into the market dynamics and organizational requirements that will define success in 2025. Several key themes emerged fr…

1
Leveraging people, processes and technology to deliver for biotech 21:35

7M ago21:35

21:35

Small and emerging biotech companies have varied challenges compared to mid-large size pharma companies, with paths that aren’t always as straightforward as taking a compound through clinical development to launch. Our biotech clients drive towards these key inflection points from proof of concept to compound development, to capital raises based on…

1
Conducting the Medical Office 24:37

8M ago24:37

24:37

When does a biotech need a Chief Medical Officer? "If you're asking, you probably needed one yesterday," suggests Dr. Benit Maru in this straight-talking episode of Emerging Biotech Leader. The SSI Strategy medical lead breaks from convention, arguing that early-stage organizations - particularly those in rare disease or novel modalities - can't af…

1
Right Time, Right Team: How to Optimize Medical Leadership 32:22

8M ago32:22

32:22

Have you ever wondered what makes a great biotech CMO? In this episode of the Emerging Biotech Leader, Dr. Steven Zelenkofske shares the practical, hard-earned insights he’s gained from his five CMO positions and multiple board roles, offering straightforward advice on how CMOs can step in early, build strong executive relationships, and drive clin…

1
How (and Why) to Maintain a Customer-Centric Focus When Planning Your Exit | Glenn Hanner 28:18

8M ago28:18

28:18

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Follow Glenn: https://www.linkedin.com/in/glenn-hanner-632291a/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I'm thrilled to reconnect with Glenn…

1
The New Board Game: Strategic Moves in Biotech 16:43

8M ago16:43

16:43

The relationship between biotech leadership and their boards is evolving, particularly as private equity takes a larger role in the industry. In this episode of the Emerging Biotech Leader, Nick Amigone from Amulet Capital Partners offers a unique perspective on building effective board relationships from the private equity vantage point. The conve…

1
Supercharging Biotechs: The Power of Strategic Board Engagement 35:24

9M ago35:24

35:24

How can biotech CEOs and their boards foster strong, trusting relationships that drive effective decision-making and long-term success? In this episode of Emerging Biotech Leader, host Kim Kushner explores this critical question together with Don de Bethizy. Don is a seasoned life sciences executive with over 30 years of experience, having served a…

1
Navigating market access in neuroscience: Challenges and strategies 26:22

9M ago26:22

26:22

Dr. Andreas Lysandropoulos, Senior Vice President and Global Therapeutic Head of Neurosciences, and Wyatt Gotbetter, Senior Vice President, Worldwide Access Consulting, join Bev Hope, Parexel’s Marketing Strategy Director, in a podcast discussion of how sponsors can build a value proposition and market access strategy for novel neurological and psy…

1
Life Science Marketing Agencies Exposed: Top Secrets Revealed | Marc Frechette 35:02

9M ago35:02

35:02

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Marc: https://www.linkedin.com/in/digitalmktggeek/ This is the chat life science marketing agencies don’t want clients to watch. In…

1
How Smart Risk Management Safeguards Your Biotech Venture 25:50

9M ago25:50

25:50

In this episode of "The Emerging Biotech Leader" podcast, host Ramin Frahood speaks with Helen Kargaryani, VP Global Head of Quality/Quality Services at SSI Strategy. With over 30 years of experience in the pharmaceutical and biotech industries, Helen shares her expertise on quality and risk management. Risk management in these industries is a crit…

1
Get More Leads with Customer Value Journey Mapping | Kathleen Mitchell 17:11

10M ago17:11

17:11

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Follow Kate: https://www.linkedin.com/in/canadiankate/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I'm joined again by Kathleen Mitchell as we d…

1
How to Start a Life Science Company: Busting 3 New Founder Misconceptions | Karthik Ramachandran 35:21

10M ago35:21

35:21

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Follow Karthik: https://www.linkedin.com/in/kansasbioengineer/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I'm joined by Karthik Ramachandran, a…

1
De-risking Drug Development | Episode 5: Expand the use and value of your product over time 34:38

10M ago34:38

34:38

De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…

1
De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval 33:53

10M ago33:53

33:53

De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…

1
Where Risk Meets Opportunity: Strategies for MedTech Success 44:57

10M ago44:57

44:57

This episode offers critical insights on leveraging risk management as a strategic advantage in medical device development. In a conversation with Ramin Farhood, Bijan Elahi, with over 30 years of experience, provides a roadmap for integrating safety considerations into innovation pipelines, potentially accelerating time-to-market and enhancing com…

1
How To Use Voice of Customer to Differentiate Your Medical Device | Glenn Hanner 36:05

10M ago36:05

36:05

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 In this episode of LifeSci Continuum, I’m joined by Glenn Hanner, FCMO and experienced marketing leader in the industry to explore how lif…

1
How Building an Online “University” Led to Record-breaking Medical Device Growth | Marc Frechette 1:01:50

10M ago1:01:50

1:01:50

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Marc: https://www.linkedin.com/in/digitalmktggeek/ About Marc: Marc is a veteran digital marketing and communications professional …

1
Using Omnichannel Marketing to Launch Your Digital Health Product | Kathleen Mitchell 34:38

10M ago34:38

34:38

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Kathleen Mitchell: https://www.linkedin.com/in/canadiankate/ About Kathleen: She is a Strategic marketing executive with 20+ years …

1
Patients as Partners: A Winning Strategy for Drug Development - Laurie Smaldone-Alsup: 37 24:25

11M ago24:25

24:25

The latest Emerging Biotech Leader podcast tackles the important topic of patient-focused drug development, offering valuable insights for the biotech industry. Our host Kim Kushner engages in an insightful dialogue with Dr. Laurie Smaldone-Alsup, SVP Regulatory Science at SSI Strategy, who brings years of hands-on regulatory experience to the conv…

1
Tackling The Biggest Life Science Product Marketing Challenges | Bill Schick 17:19

11M ago17:19

17:19

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430By Bill Schick FCMO

1
How to Grow by Creating a Culture of Leadership in Your Life Sciences Company | Dr. Russ Ouellette 59:03

11M ago59:03

59:03

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Russ on LinkedIn: https://www.linkedin.com/in/russouellette/ Russ's Podcast: https://www.youtube.com/@RussOuellette @RussOuellette …

1
Win Life Science Product Management with Data and A Strong Business Case | Kate French 21:35

11M ago21:35

21:35

Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://www.youtube.com/@BillSchickFCMO Audio Podcast: https://www.buzzsprout.com/2380430 Follow Kate: https://www.linkedin.com/in/katherine-king-french-pmp-b14a7716/ In this episode, I’m joined by Kate French to explore the cri…

1
Forecasting your Exit (as a Life Science Company) | Dave Iannetta 22:27

11M ago22:27

22:27

When it comes to product launches, we tend to hyperfocus on just simply getting everything to launch and we tend to leave the exit strategy to the end. On this episode of LifeSci Continuum, we are joined by David Iannetta as we learn that it is truly never too early to start preparing for your exit. Follow Bill: https://www.linkedin.com/in/foundera…

1
Preparing for your Life Science Product Launch | Christi Unger 30:37

11M ago30:37

30:37

Launching a product is a rollercoaster for product managers and marketers. But jumping in right before the finish line is a different type of ride. In this episode, we are joined by Christi Unger as we discuss her experience launching life-science products and the lessons she learned. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact …

1
The Keys for Building High Performance Life Science Teams | Kate French 22:21

11M ago22:21

22:21

Without two important team traits, your team might be missing their mark. On this week's episode, Kate French joins us to talk about her experience working with engineering and what goes into building effective, high-performing teams in your life sciences company. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshage…

1
Rare Diseases, Real Lives: Bridging Patient Needs and Drug Development - Dr. Edward M. Kaye : 36 26:42

11M ago26:42

26:42

On this episode of Emerging Biotech Leader, Kim Kushner sits down with Edward M Kaye, M.D., CEO and director of Stoke Therapeutics, to talk about his work in rare disease drug development. Throughout their conversation, Ed describes the challenges of first-in-class drug development. He explains the importance of understanding diseases thoroughly an…

1
Podcast: Accelerated approvals – what’s next, confirmatory trials, access, and pricing 12:51

11M ago12:51

12:51

Focusing on cell and gene therapies, this podcast discusses the use of accelerated approvals for fast tracking promising novel medicines through clinical development to registration.By PAREXEL

1
Go Above & Beyond with Your Next Medical Device Launch (or Exit) | David Iannetta 46:56

12M ago46:56

46:56

You might be thinking about highlighting the features and benefits of your medical device. Well, David Iannetta joins us to talk about how looking past the status quo could be the X-Factor for your next Product Launch (or Exit). Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast:…

1
Product Management Basics (for Life Science Companies) | Jim Dembkoski 59:37

12M ago59:37

59:37

On this episode, we are joined by Jim Dembkoski who is bringing 15 years of product management advice to the table. Join us as we discuss how Jim got into Product Management and the key lessons he learned along the way. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ Video Podcast: https://…

1
Welcome to LifeSci Continuum with Bill Schick | Podcast Introduction 2:14

12M ago2:14

2:14

Kicking off the LifeSci Continuum, we are going to cover almost every aspect of Commercialization and product life cycle stage. From Launch to Exit, we go deep with expert interviews, tips, shortcuts, and best practices to help you level up. Follow Bill: https://www.linkedin.com/in/founderandcdo/ Contact Bill: https://meshagency.com/lets-connect/ V…

1
Real-World Evidence and Putting Patients at the Center of Drug Development - Dr. Chantal van Gils : 35 22:46

12M ago22:46

22:46

Summary: In this episode, host Kim Kushner is joined by Dr. Chantal van Gils, a leading expert in evidence and value strategy at SSI Strategy. Building on the previous podcast discussion with Christian Howell of Cognito, this episode delves into three key themes:1) differing evidentiary requirements for medical devices versus pharmaceuticals, 2) th…

1
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept 39:29

1y ago39:29

39:29

De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial succes…